Introduction {#s1}
============

Schistosomiasis is one of the most common human parasitic diseases whose socioeconomic impact affects people in developing nations in the tropics and sub-tropics. Preventive chemotherapy (PC) with Praziquantel is required in 52 countries, where only in 2017, 220 million people needed PC for schistosomiasis; however, only 44.9% of this demand was covered ([@B61]). Despite the control efforts, schistosomiasis continues to be a major public health problem, principally due to schistosomiasis-related morbidity ([@B18]; [@B47]).

*Schistosoma mansoni* kinome containing 252 eukaryotic kinase proteins (ePKs) was first described by Andrade and co-authors ([@B2]) based on an earlier version of *S. mansoni* genome ([@B6]). Recently, 351 kinase genes with evidence of being transcribed in nearly all adult stages were described, of which 268 were PKs and an additional 83 were non-PKs ([@B23]). Although protein kinases have been recognized for years as suitable targets for drug development ([@B13]; [@B11]), experimental functional evidence exists for only 40 *S. mansoni* proteins, showing that there is still need for further research.

The c-Jun N-terminal kinase signaling pathway is involved in the developmental regulation of various organisms. Its role has already been demonstrated in oocyte maturation and embryogenesis of *Xenopus laevis* ([@B5]) and in the spindle assembly during the mouse oocyte meiotic maturation ([@B26]). In *S. mansoni*, SmJNK (Smp_172240) was previously characterized, demonstrating its importance for the establishment of infection in the mammalian host ([@B1]). SmJNK knockdown caused damage to the adult worms' tegument and impaired the maturation of vitelline organs. This resulted in lower oviposition and greater susceptibility to the host immune system. Furthermore, the SmJNK ortholog in *Schistosoma haematobium* was pointed as one of the prioritized druggable kinase targets due to its essentiality based on lethal gene knock-down or knock-out phenotypes in other organisms ([@B55]).

Here, we sought to assess the role of SmJNK in adult worms *in vitro*, further advancing in unraveling the functions of this critical protein and putative druggable target. Also, we elucidated genes that are target of regulation by SmJNK knockdown, aiming to identify novel parasite-specific targets in addition to contributing to a better understanding of this signaling pathway. Additionally, we checked for a crosstalk between SmJNK pathway and the previously reported data from Smp38 ([@B4]). Finally, we identified specific targets that correlate with previously observed phenotypes of developmental impairment ([@B1]; [@B4]) which is highly desirable for the design of new anti-schistosome drugs.

Methods {#s2}
=======

Parasites {#s2_1}
---------

*S. mansoni* adult worms of LE strain were recovered from hamster periportal perfusion 40 days after cercariae percutaneous infection ([@B50]). Schistosomula were obtained by mechanical transformation of cercariae as previously described ([@B43]). Cercariae were supplied by the Mollusk Room 'Lobato Paraense' of the René Rachou Institute--FIOCRUZ, where the parasite cycle is routinely maintained. The sporocysts were prepared following the protocol previously described ([@B45]). This work was approved by the Oswaldo Cruz Foundation's Ethics Committee for Animal Use (CEUA) under number LW12/16, according to the Brazilian national guidelines set out in Law 11794/08.

DsRNA Synthesis {#s2_2}
---------------

For the dsRNA synthesis, an SmJNK mRNA fragment corresponding to a region of approximately 570 bp, previously cloned into pGEM-T Easy vector, was amplified by PCR. Primers and cycling conditions used in this study were previously designed and established by Andrade and collaborators ([@B1]). After amplification, PCR products were separated on 1% agarose gels, purified using QIAquick Gel Extraction Kit (Qiagen) and used as the template for dsRNA synthesis. DsRNA synthesis was performed using the T7 RiboMAX Express RNAi Systems kit (Promega) according to the supplier's protocol. DsRNA integrity and annealing were verified on 1% agarose electrophoresis.

SmJNK Knockdown in Adult Worms by RNA Interference {#s2_3}
--------------------------------------------------

After perfusion, males and females adult worms were washed and separated manually. Then, eight males and eight females were placed separately in each well containing 100 μL of RPMI 1640 medium with 25 μg of dsRNA, in two technical replicates. The worms were electroporated with specific SmJNK dsRNA or unspecific GFP dsRNA into 4 mm cuvettes at 125 V for 20 ms and cultivated in 24-well plates with 1 mL RPMI 1640 medium supplemented with 10% heat-inactivated Fetal Bovine Serum and 2% Penicillin/Streptomycin. Unless stated otherwise, all culture reagents were from Gibco, Thermo Fisher Scientific. Worm motility was assessed using the WormAssay software ([@B40]) for 10 days, in which eight worms were cultured in 24-well tissue culture plates containing 1 mL of medium. Similarly, to count the number of eggs laid, eight worm pairs were electroporated and cultured in 6-well plates, the medium was changed daily, and the eggs counted. Also, on days 3, 5, 7, and 10 after electroporation, two worm pairs per day were removed and macerated with TRIzol Reagent (Thermo Fisher Scientific) for RNA extraction as described below. SmJNK expression in adult worms was assessed by quantitative real-time PCR (RT-qPCR). Experiments were performed in three biological replicates. Data were analyzed using unpaired t-test with Welch's correction.

SmJNK Knockdown in Schistosomula by RNA Interference {#s2_4}
----------------------------------------------------

Schistosomula cultures (∼500,000 worms/condition) were maintained in bottles with 10 mL of Glasgow Minimum Essential Medium (GMEM) (Sigma-Aldrich) supplemented with 0.2 µM triiodothyronine (Sigma-Aldrich); 0.1% glucose; 0.1% lactalbumin (Sigma-Aldrich); 20 mM HEPES; 0.5% MEM vitamin solution (Gibco, Thermo Fisher Scientific); 5% Schneider's Insect Medium (Sigma-Aldrich); 0.5 µM Hypoxanthine (Sigma-Aldrich), 1 µM hydrocortisone (Sigma-Aldrich), 1% Penicillin/Streptomycin (Gibco, Thermo Fisher Scientific), and 2% heat-inactivated Fetal Bovine Serum (Gibco, Thermo Fisher Scientific). SmJNK dsRNA was added shortly after schistosomula transformation to a final concentration of 100 nM. Cultures were kept in a Bio-Oxygen Demand incubator (B.O.D.) at 37°C, 5% CO~2~, and 95% humidity. Two independent biological replicates were performed. Data were analyzed using unpaired t-test with Welch's correction.

Total RNA Extraction {#s2_5}
--------------------

RNA extraction was performed three, five, seven, and ten days after adult worm electroporation with SmJNK dsRNA. For schistosomula, the RNA extraction was performed two days after exposure to SmJNK dsRNA, as previously shown, reduction in transcript levels was greater at this exposure time ([@B1]). For RNA extraction, TRIzol Reagent (Invitrogen) was used associated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's guidelines. Samples were treated with Turbo DNase (Ambion, Thermo Fisher Scientific) for removal of genomic DNA. RNAs were quantified using a Qubit Fluorometer 2.0 (Invitrogen) and, for RNASeq, RNA integrity was assessed using the Agilent RNA 6000 Pico kit and BioAnalyzer 2100 (Agilent Technologies).

Gene Expression Analysis by Quantitative Real-Time PCR (RT-qPCR) {#s2_6}
----------------------------------------------------------------

The cDNA was synthesized using SuperScript™ III Reverse Transcriptase (Invitrogen, Thermo Fisher Scientific) or Illustra Ready-To-Go RT-PCR Beads (GE Healthcare). qPCR was performed using Power SYBR^®^ Green Master mix (Applied Biosystems, Thermo Fisher Scientific) on an ABI 7500 RT-PCR system (Applied Biosystems, Thermo Fisher Scientific) to evaluate SmJNK knockdown. Primers and cycling conditions used in this study were previously designed and established by Andrade and collaborators ([@B1]). Cytochrome C oxidase I gene (Smp_900000) was used to normalize RNA input from schistosomula ([@B1]). FAD dependent oxidoreductase domain containing protein (SmFAD, Smp_089880) and actin-related protein 10 (Sm-arp 10, Smp_093230) genes were used to normalize RNA input from adult worms ([**Supplementary Table S1**](#SM2){ref-type="supplementary-material"}). In each plate, two internal controls were included to assess both reagent and genomic DNA contamination (RNA samples). Post-RNAi, SmJNK transcript levels were analyzed using the relative 2^-ΔΔCt^ method ([@B34]) and expressed as the percentage of difference compared to the untreated or unspecific control.

To evaluate SmJNK expression among the different stages of *S. mansoni* we used qPCR absolute quantification using copy number standards, employing a curve containing five points of an SmJNK clone 10-fold dilution. The copy number of each dilution was calculated by the ratio of the clone molecular mass to the Avogadro constant as described ([@B33]), and the absolute copy number of the SmJNK transcript at each stage was estimated by interpolation of the sample Ct using a standard curve, and expressed as copy number per ng of total RNA.

High-Throughput mRNA Sequencing (RNASeq) {#s2_7}
----------------------------------------

After confirming SmJNK knockdown, 2 µg of total RNA extracted from untreated and SmJNK knocked-down schistosomula, two days after dsRNA exposure, were subjected to mRNA purification, fragmentation, cDNA synthesis, and library construction. Next generation barcode multiplexed sequencing libraries were constructed using the TruSeq stranded mRNA kit (Illumina) and pooled in equimolar concentrations. Libraries were sequenced as 100-base paired-end reads using HiSeq 2500 (Illumina) using a HiSeq Rapid SBS sequencing kit v.2 (Illumina). Raw sequence data were preprocessed using the standard Illumina pipeline to segregate multiplexed reads. Sequence quality was assessed using the FastQC program (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc>). Reads were then mapped to the *S. mansoni* reference genome (v. 7) using the STAR program (v. 2.6.1d) using default parameters except the following: --outSJfilterReads Unique, --sjdbOverhang 99, --outFilterType BySJout, --outFilterMultimapNmax 20, --alignSJoverhangMin 8, --alignIntronMin 25, and --outSAMattributes All ([@B14]).

Screening of Differentially Expressed Genes {#s2_8}
-------------------------------------------

Downstream analysis was carried out using the R statistical software package (v. 3.3.2) ([@B51]). To ascertain genes that significantly change after SmJNK dsRNA exposure, we used DESeq2 (v. 1.12.4) ([@B35]) to normalize the data and performed statistical analysis. Genes with adjusted p-value \<0.01 were considered significantly differentially expressed. Clustering analysis was performed using the heatmap function from the gplots (v. 3.0.1) package and PCA plots were generated using the ggplot2 (v. 2.1.1) package.

Gene ontology (GO) ([@B3]; [@B57]) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) ([@B28]; [@B29]; [@B27]) pathway analysis were used to identify the enriched molecular functions and associated biological pathways of differentially expressed genes (DEGs). The g:Profiler tool (version e95_eg42_p13_f6e58b9) ([@B53]; [@B52]) was applied to perform the GO enrichment and KEGG pathway analysis. The g:SCS method was applied for computing multiple testing correction using the padjusted values with a 0.05 threshold. The ReViGO tool ([@B56]) was used to cluster, summarize, and visualize the list of significantly enriched GO terms based on their semantic similarities (Allowed similarity: 0.4).

We also compared DEGs of schistosomula SmJNK knocked-down with those found in schistosomula Smp38 knocked-down ([@B4]). The down-regulated DEGs that overlap in both datasets were subjected to the BioMart tool (<https://parasite.wormbase.org/info/Tools/biomart.html>) from WormBase ParaSite ([@B25]) to search for orthologs in the nematode Caenorhabditis elegans. The orthologous genes were then analyzed using the Worm Enrichr enrichment analysis tool for *C. elegans* (<https://amp.pharm.mssm.edu/WormEnrichr/>) to search for the RNAi phenotypes associated with this gene list ([@B12]; [@B32]).

Quantitative Real-Time PCR Validation of Differentially Expressed Genes {#s2_9}
-----------------------------------------------------------------------

Quantitative PCR was performed to validate the expression levels of selected differentially expressed genes. Ten genes were selected randomly; whereas five of them are among the DEGs exhibiting large fold changes ([**Supplementary Table S1**](#SM2){ref-type="supplementary-material"}). Specific primers were designed using PrimerQuest tool (<https://www.idtdna.com/Primerquest/Home/Index>) and/or Primer3 software (<http://primer3.ut.ee/>) and obtained from Integrated DNA Technologies (IDT). The sequences of all primers and the final concentrations established for each qPCR reaction are presented in [**Supplementary Table S1**](#SM2){ref-type="supplementary-material"}. PCR efficiency for each pair of specific primers was estimated by titration analysis to be 100% ± 10%. RNA extraction, purification, cDNA synthesis, and RT-qPCR reactions were carried as described above. SmFAD and Sm-arp 10 genes were used to normalize RNA input ([**Supplementary Table S1**](#SM2){ref-type="supplementary-material"}).

Results {#s3}
=======

SmJNK Expression Levels Among *S. Mansoni* Developmental Stages {#s3_1}
---------------------------------------------------------------

The expression profile of SmJNK in developmental stages of *S. mansoni* (cercariae, two and seven days schistosomula, adult males, adult females, and sporocysts) was investigated by quantitative PCR. Absolute quantification was employed to assess SmJNK expression among the different developmental stages. The SmJNK gene exhibited the highest expression levels (∼4,000 copies/ng of total RNA) in two days schistosomula. This was six times the amount presented in adult males that exhibited the second highest expression levels (∼635 copies/ng of total RNA) ([**Figure 1A**](#f1){ref-type="fig"}). Cercariae, sporocysts and seven days transformed schistosomula presented approximately the same amount of SmJNK transcripts.

![SmJNK expression profile among developmental stages of *S. mansoni* and after RNAi of adult worms *in vitro*. **(A)** SmJNK transcript levels in the different *S. mansoni* life stages; cercariae, two and seven days schistosomula, males, females, and sporocysts. Bar graph depicting the absolute SmJNK transcript levels presented as copy number per ng of total RNA. Bars represent the standard deviation of the mean of three technical replicates. **(B)** Bar graph depicting the relative SmJNK transcript levels in adult worms three, five, seven, and ten days after electroporation with SmJNK dsRNA. Bars represent the relative values of SmJNK transcripts compared to the untreated control (▪), or to the unspecific control-GFP (▪). The dashed line represents the values of the normalized controls. Data are represented as mean fold-difference (+/− SE). Asterisks represent statistically significant differences. Data were analyzed using Unpaired t-test with Welch's correction (N=3, \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001). **(C)** SmJNK transcript levels in schistosomula exposed to SmJNK dsRNA before RNASeq experiments. Bar graph depicting relative SmJNK transcripts levels in schistosomula two days after exposure to SmJNK dsRNA (▪) compared to the untreated control (▪). Data are represented as mean fold-differences (+/− SE). Transcript levels were determined by RT-qPCR and data analyzed using the ΔΔCt method (\*p \< 0.05, N = 2). Unpaired *t* test with Welch's correction.](fgene-10-01036-g001){#f1}

SmJNK Knockdown in Adult Schistosomes {#s3_2}
-------------------------------------

Adult worms electroporated with SmJNK dsRNA showed up to 62% reduction in SmJNK transcript levels on the fifth day after electroporation ([**Figure 1B**](#f1){ref-type="fig"}). After the successful establishment of SmJNK knockdown in adults, we evaluated phenotypic changes, including worm movement and oviposition. SmJNK knockdown in adult worms did not result in any significant changes in male nor female movement for ten days ([**Supplementary Figures S1A, B**](#SM1){ref-type="supplementary-material"}). However, a significant reduction of 67% in egg laying was observed in worms electroporated with SmJNK dsRNA ([**Figure 2**](#f2){ref-type="fig"}).

![*In vitro* SmJNK knockdown effects in adult schistosome oviposition. Bar graph depicting the percentage of eggs released during 10 days after electroporation with SmJNK dsRNA (▪) compared to untreated control (▪). Data were analyzed using Unpaired t-test with Welch's correction (N = 3; \*p \< 0.05).](fgene-10-01036-g002){#f2}

SmJNK Knockdown in Schistosomula and Quality Assessment of RNASeq Libraries {#s3_3}
---------------------------------------------------------------------------

After confirming successful SmJNK knockdown by RT-qPCR in schistosomula ([**Figure 1C**](#f1){ref-type="fig"}), four paired-end libraries were generated yielding a total of 158 M paired-end reads with 100 bps as average sequence length, with 38--40% guanine-cytosine (GC) content ([**Table 1**](#T1){ref-type="table"}). FastQC quality assessment indicated that RNASeq data presented a high quality and were adequate for downstream transcriptome analysis. Raw reads were submitted to Sequence Read Archive (SRA; <http://www.ncbi.nlm.nih.gov/sra>), under accession numbers: PRJNA354932 and PRJNA492452. Sequence mapping to *S. mansoni* reference genome (v. 7) resulted in uniquely mapped reads ranging from 80.94 - 84.16%.

###### 

Summary of sequenced datasets and mapping to the *S. mansoni* reference genome.

  Sample        Replicate   Input reads number   Uniquely mapped reads (%)   Reads mapped to multiple loci (%)
  ------------- ----------- -------------------- --------------------------- -----------------------------------
  Control       1           46650550             80,94                       15,35
  2             58555610    82,41                13,86                       
  SmJNK dsRNA   1           29013869             81,31                       11,75
  2             23856371    84,16                10,87                       

The correlation degree between the biological samples was investigated by hierarchical clustering using the heatmap function of the DESeq2 package and means of the Euclidean distances. Clustering analysis grouped libraries from biological replicates in the same branch ([**Figure 3A**](#f3){ref-type="fig"}). Principal component analysis (PCA) was also performed with the genes by multidimensional scaling of the data matrix ([**Figure 3B**](#f3){ref-type="fig"}). The PCA plot of the first two components showed a clear separation between the control and SmJNK dsRNA treated samples in the first dimension.

![Correlation plots of SmJNK knocked-down schistosomula libraries. **(A)** Heatmap showing the Euclidean distances between the RNASeq libraries of schistosomula treated with SmJNK dsRNA and the untreated control. **(B)** Graph of the first two principal components (PCA) of schistosomula transcriptome expression patterns treated with SmJNK dsRNA compared to the untreated control. The colors represent each treatment: Control (orange) and SmJNK dsRNA (light blue), and the shapes represent each of the two biological replicates (circle and triangle).](fgene-10-01036-g003){#f3}

Potential SmJNK Regulated Gene Targets Identified in Schistosomula After RNAi {#s3_4}
-----------------------------------------------------------------------------

After checking for data consistency and sample quality, the transcriptional profile of schistosomula two days after SmJNK dsRNA exposure was compared to the profile of the untreated control using the DESeq2 package in R. We found 495 DEGs using the DESeq2 package (padj \<0.01) ([**Figure 4A**](#f4){ref-type="fig"}). Ten of the DEGs identified among the transcripts were selected for validation by RT-qPCR ([**Figure 4B**](#f4){ref-type="fig"}) ([**Supplementary Table S1**](#SM2){ref-type="supplementary-material"}). All the analyzed genes showed consistent expression trend between the RNASeq and RT-qPCR analyses, although with some differences in log~2~FoldChange values, which is expected between two different methodologies and among different biological replicates. Significant correlation (R^2^ = 0.7474, p = 0.0012) between the log~2~FoldChange of the employed methodologies confirms the accuracy of the data ([**Figure 4C**](#f4){ref-type="fig"}).

![Differentially expressed genes (DEGs) after SmJNK knockdown in schistosomula. **(A)** MA plot depicting a DESeq2 analysis to identify DEGs between SmJNK dsRNA and untreated control. The log-fold change for each transcript is plotted against the mean of normalized counts; each point corresponds to one gene. Significantly altered gene expressions are highlighted in red (padj \< 0.01). **(B)** RT-qPCR validation of the differentially expressed genes in response to SmJNK knockdown. Ten DEGs were selected from a range of up-regulated and down-regulated genes. Expression levels were quantified by RT-qPCR (gray) and the results were compared to those obtained by the RNASeq approach (black). **(C)** Pearson's correlation of Log~2~FoldChange in differentially expressed transcripts between RNASeq and RT-qPCR analysis.](fgene-10-01036-g004){#f4}

A list of all statistically significant DEGs from schistosomula exposed to SmJNK dsRNA can be found in the [**Supplementary Table S2**](#SM3){ref-type="supplementary-material"}. Of the 495 DEGs detected in the samples in which SmJNK expression was reduced, 373 are down-regulated and 122 up-regulated in comparison to untreated controls.

Gene Set Enrichment Analysis {#s3_5}
----------------------------

The g:Profiler tool was used to elucidate the functional roles of the 495 DEGs. DEGs were categorized into three GO categories (GO Biological Process, GO Molecular Function, and GO Cell Component) and KEGG Pathways. The significantly enriched subcategories are shown in [**Figure 5**](#f5){ref-type="fig"} and [**Supplementary Table S3**](#SM2){ref-type="supplementary-material"}. We observed a decrease in expression for genes encoding proteins related to (1) the ribosome structural composition, (2) cytoskeleton-related, (3), purine nucleotide metabolism (4) protein folding, (5) splicing mechanisms, (6) phagosomes, and (7) binding to nucleic acids. For DEGs that showed increased expression, no subcategory showed significant enrichment ([**Figure 5A**](#f5){ref-type="fig"}).

![Gene Ontology Enrichment of down-regulated genes from SmJNK knockdown schistosomula. **(A)** Manhattan plot illustrating the enrichment analysis results separated into four categories: GO : MF (Molecular Function), GO : BP (Biological Process), GO : CC (Cellular Component), and KEGG Pathways. The number in the source name in the x-axis labels shows how many significantly enriched terms were found. The circle corresponds to term size. The term location on the x-axis is fixed and terms from the same GO subtree are located closer to each other. Interactive graph of the representative subset of the GO terms related to biological process **(B)** and molecular function **(C)** enriched in down-regulated genes from SmJNK knockdown schistosomula. Bubble colors indicate the p-value and size indicates the frequency of the GO term in the underlying Gene Ontology Annotation database. Highly similar GO terms are linked by edges, where the line width indicates the degree of similarity.](fgene-10-01036-g005){#f5}

After summarizing the list of GO terms using the ReViGO tool, we found not redundant GO terms and ordered according to the log~10~ p-value. Focusing on enriched GO categories from Biological Process categories found among the down-regulated genes, we found that 23 GOs were representative in SmJNK knockdown schistosomula, due to their uniqueness, we highlight: protein folding, biosynthetic process, adenosine triphosphate (ATP) hydrolysis coupled cation transmembrane transport, ATP metabolic process, regulation of cellular catabolic process, gene expression, nitrogen compound metabolic process, RNA splicing, cellular amide metabolic process, protein import into nucleus, positive regulation of proteolysis, translational initiation, and cellular nitrogen compound metabolic process ([**Figure 5B**](#f5){ref-type="fig"}, [**Table 2**](#T2){ref-type="table"}). The GO terms included in the molecular function category were summarized in 22 GO terms. We draw attention to structural constituent of ribosome, hydrogen ion transmembrane transporter activity, unfolded protein binding, lactate dehydrogenase activity, peptidyl-prolyl cis-trans isomerase activity, drug binding, translation initiation factor activity, and nucleic acid binding ([**Figure 5C**](#f5){ref-type="fig"}, [**Table 2**](#T2){ref-type="table"}).

###### 

List of enriched gene ontology (GO) from DEGs down-regulated in schistosomula SmJNK knockdown. The analysis is separated into two GO categories: Biological Process and Molecular Function. The dispensable GO terms are depicted in italic. The values of log~10~p-value refers to log~10~ of padjusted values obtained using g:Profiler toll.

  Biological process                                                                                                                      
  -------------------- ------------------------------------------------------------------------------------ ---------- ----------- ------ ------
  GO:0006457           protein folding                                                                      0.903%     --72.699    0.93   0.00
  GO:0008150           biological_process                                                                   100,000%   --102.197   1.00   0.00
  GO:0008152           metabolic process                                                                    75,387%    --79.533    0.99   0.00
  GO:0009058           biosynthetic process                                                                 31,611%    --117.905   0.93   0.00
  GO:0009987           cellular process                                                                     63,780%    --117.165   0.99   0.00
  GO:0099132           ATP hydrolysis coupled cation transmembrane transport                                0.729%     --46.910    0.79   0.00
  GO:0015991           ATP hydrolysis coupled proton transport                                              0.163%     --14.544    0.77   0.80
  GO:0099131           ATP hydrolysis coupled ion transmembrane transport                                   0.996%     --14.544    0.79   0.96
  GO:0009206           purine ribonucleoside triphosphate biosynthetic process                              0.485%     --25.175    0.56   0.98
  GO:0009145           purine nucleoside triphosphate biosynthetic process                                  0.485%     --25.175    0.57   0.92
  GO:0098662           inorganic cation transmembrane transport                                             1,858%     --13.551    0.79   0.86
  GO:0090662           ATP hydrolysis coupled transmembrane transport                                       1,001%     --14.544    0.85   0.46
  GO:1902600           hydrogen ion transmembrane transport                                                 1,015%     --42.701    0.75   0.82
  GO:0006754           ATP biosynthetic process                                                             0.432%     --23.137    0.54   0.97
  GO:0015988           energy coupled proton transmembrane transport, against electrochemical gradient      0.170%     --14.544    0.78   0.69
  GO:0015985           energy coupled proton transport, down electrochemical gradient                       0.411%     --23.137    0.76   0.88
  GO:0015986           ATP synthesis coupled proton transport                                               0.411%     --23.137    0.42   0.88
  GO:0009201           ribonucleoside triphosphate biosynthetic process                                     0.577%     --22.206    0.56   0.95
  GO:0046034           ATP metabolic process                                                                1,263%     --37.694    0.54   0.04
  GO:0009205           purine ribonucleoside triphosphate metabolic process                                 1,366%     --25.175    0.57   0.97
  GO:0009259           ribonucleotide metabolic process                                                     2,752%     --18.803    0.58   0.92
  GO:0019693           ribose phosphate metabolic process                                                   3,032%     --18.803    0.66   0.67
  GO:0006163           purine nucleotide metabolic process                                                  2,435%     --18.803    0.55   0.94
  GO:0009144           purine nucleoside triphosphate metabolic process                                     1,401%     --25.175    0.57   0.94
  GO:0009142           nucleoside triphosphate biosynthetic process                                         0.651%     --22.206    0.57   0.86
  GO:0009141           nucleoside triphosphate metabolic process                                            1,605%     --19.590    0.61   0.71
  GO:0009150           purine ribonucleotide metabolic process                                              2,353%     --20.776    0.55   0.89
  GO:0009199           ribonucleoside triphosphate metabolic process                                        1,458%     --22.206    0.57   0.96
  GO:0031329           regulation of cellular catabolic process                                             0.093%     --22.161    0.66   0.05
  GO:0009896           positive regulation of catabolic process                                             0.072%     --20.507    0.69   0.92
  GO:1901575           organic substance catabolic process                                                  4,612%     --14.509    0.71   0.60
  GO:0009894           regulation of catabolic process                                                      0.146%     --16.724    0.79   0.43
  GO:1903364           positive regulation of cellular protein catabolic process                            0.038%     --20.507    0.60   0.94
  GO:1903362           regulation of cellular protein catabolic process                                     0.062%     --17.608    0.61   0.91
  GO:1903052           positive regulation of proteolysis involved in cellular protein catabolic process    0.034%     --20.507    0.61   0.97
  GO:1903050           regulation of proteolysis involved in cellular protein catabolic process             0.056%     --17.608    0.60   0.97
  GO:0031331           positive regulation of cellular catabolic process                                    0.058%     --20.507    0.64   0.97
  GO:0051603           proteolysis involved in cellular protein catabolic process                           0.759%     --15.585    0.62   0.73
  GO:0044257           cellular protein catabolic process                                                   0.772%     --14.580    0.63   0.94
  GO:1901800           positive regulation of proteasomal protein catabolic process                         0.030%     --20.507    0.61   0.92
  GO:0061136           regulation of proteasomal protein catabolic process                                  0.048%     --17.608    0.60   0.95
  GO:0045732           positive regulation of protein catabolic process                                     0.054%     --20.507    0.62   0.90
  GO:0010467           gene expression                                                                      19,671%    --154.664   0.81   0.07
  GO:0044260           cellular macromolecule metabolic process                                             34276%     --79.682    0.75   0.42
  GO:0044237           cellular metabolic process                                                           53,061%    --116.849   0.87   0.08
  GO:0006807           nitrogen compound metabolic process                                                  38,744%    --86.404    0.93   0.09
  GO:0044238           primary metabolic process                                                            53,743%    --90.300    0.92   0.11
  GO:0071704           organic substance metabolic process                                                  58,357%    --83.098    0.92   0.12
  GO:0043170           macromolecule metabolic process                                                      39,491%    --78.359    0.85   0.18
  GO:0008380           RNA splicing                                                                         0.413%     --16.333    0.77   0.20
  GO:0043603           cellular amide metabolic process                                                     6,879%     --235.632   0.78   0.20
  GO:0006606           protein import into nucleus                                                          0.102%     --15.977    0.82   0.24
  GO:0034504           protein localization to nucleus                                                      0.129%     --15.977    0.88   0.75
  GO:0051170           nuclear import                                                                       0.107%     --13.547    0.87   0.88
  GO:0045862           positive regulation of proteolysis                                                   0.078%     --20.507    0.69   0.27
  GO:0006413           translational initiation                                                             0.518%     --13.840    0.65   0.29
  GO:0006412           translation                                                                          5,686%     --258.077   0.55   0.66
  GO:0006518           peptide metabolic process                                                            5,961%     --248.427   0.67   0.88
  GO:0043604           amide biosynthetic process                                                           6,374%     --247.598   0.67   0.89
  GO:0043043           peptide biosynthetic process                                                         5,770%     --255.362   0.64   0.93
  GO:0034641           cellular nitrogen compound metabolic process                                         34,137%    --138.052   0.74   0.31
  GO:1901576           organic substance biosynthetic process                                               30,365%    --117.012   0.74   0.59
  GO:1901564           organonitrogen compound metabolic process                                            17,886%    --107.455   0.77   0.42
  GO:0009059           macromolecule biosynthetic process                                                   19,548%    --131.642   0.72   0.50
  GO:0044249           cellular biosynthetic process                                                        30,048%    --115.243   0.73   0.66
  GO:0044271           cellular nitrogen compound biosynthetic process                                      22,502%    --141.400   0.68   0.45
  GO:0034645           cellular macromolecule biosynthetic process                                          19,291%    --133.236   0.68   0.54
  GO:0019538           protein metabolic process                                                            18,489%    --96.161    0.80   0.34
  GO:0072521           purine-containing compound metabolic process                                         2,673%     --17.982    0.73   0.35
  GO:1901566           organonitrogen compound biosynthetic process                                         14,064%    --207.359   0.66   0.51
  GO:0044267           cellular protein metabolic process                                                   14,293%    --109.414   0.72   0.38
  GO:0003674           molecular_function                                                                   100,000%   --174.435   1.00   0.00
  GO:0003735           structural constituent of ribosome                                                   2,679%     --276.945   0.90   0.00
  GO:0005201           extracellular matrix structural constituent                                          0.028%     --52.190    0.91   0.56
  GO:0005200           structural constituent of cytoskeleton                                               0.079%     --23.341    0.90   0.61
  GO:0005198           structural molecule activity                                                         3,268%     --331.562   0.95   0.00
  GO:0005488           binding                                                                              55,656%    --113.354   0.98   0.00
  GO:0015078           hydrogen ion transmembrane transporter activity                                      0.926%     --42.870    0.80   0.00
  GO:0022853           active ion transmembrane transporter activity                                        0.923%     --17.206    0.80   0.68
  GO:0044769           ATPase activity, coupled to transmembrane movement of ions, rotational mechanism     0.363%     --14.218    0.63   0.89
  GO:0046933           proton-transporting ATP synthase activity, rotational mechanism                      0.325%     --23.533    0.62   0.81
  GO:0019829           cation-transporting ATPase activity                                                  0.609%     --17.206    0.61   0.94
  GO:0042625           ATPase coupled ion transmembrane transporter activity                                0.853%     --17.206    0.60   0.88
  GO:0042623           ATPase activity, coupled                                                             2,501%     --32.190    0.67   0.00
  GO:0016462           pyrophosphatase activity                                                             7,130%     --24.489    0.66   0.92
  GO:0016818           hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides   7,190%     --23.585    0.66   0.92
  GO:0036402           proteasome-activating ATPase activity                                                0.005%     --22.947    0.77   0.43
  GO:0017111           nucleoside-triphosphatase activity                                                   6774%      --26.352    0.66   0.85
  GO:0016887           ATPase activity                                                                      4,560%     --18.342    0.67   0.74
  GO:0051082           unfolded protein binding                                                             0.486%     --42.881    0.89   0.00
  GO:0004457           lactate dehydrogenase activity                                                       0.034%     --19.668    0.92   0.02
  GO:0004459           L-lactate dehydrogenase activity                                                     0.018%     --19.668    0.92   0.46
  GO:0003755           peptidyl-prolyl cis-trans isomerase activity                                         0.359%     --15.208    0.91   0.03
  GO:0016859           cis-trans isomerase activity                                                         0.364%     --15.208    0.91   0.63
  GO:0008144           drug binding                                                                         0.178%     --15.902    0.90   0.04
  GO:0003743           translation initiation factor activity                                               0.411%     --18.402    0.85   0.05
  GO:1901363           heterocyclic compound binding                                                        41,115%    --170.093   0.81   0.08
  GO:0097367           carbohydrate derivative binding                                                      17,252%    --31.349    0.84   0.20
  GO:0043168           anion binding                                                                        20,942%    --31.876    0.81   0.21
  GO:0003676           nucleic acid binding                                                                 21,226%    --128.362   0.77   0.21
  GO:0036094           small molecule binding                                                               21,337%    --33.401    0.83   0.21
  GO:0043167           ion binding                                                                          33,492%    --40.525    0.82   0.26
  GO:0003723           RNA binding                                                                          5,283%     --177.913   0.81   0.29
  GO:0097159           organic cyclic compound binding                                                      41,137%    --169.872   0.81   0.29
  GO:0032555           purine ribonucleotide binding                                                        16,057%    --34.104    0.64   0.31
  GO:0017076           purine nucleotide binding                                                            16,107%    --33.609    0.66   0.70
  GO:0030554           adenyl nucleotide binding                                                            14,356%    --15.611    0.65   0.81
  GO:0035639           purine ribonucleoside triphosphate binding                                           15,815%    --32.542    0.65   0.70
  GO:0005524           ATP binding                                                                          14,125%    --14.318    0.64   0.81
  GO:0000166           nucleotide binding                                                                   20,185%    --32.657    0.65   0.75
  GO:0032559           adenyl ribonucleotide binding                                                        14,309%    --15.755    0.65   0.85
  GO:0032553           ribonucleotide binding                                                               16,747%    --33.282    0.65   0.80
  GO:1901265           nucleoside phosphate binding                                                         20,185%    --32.657    0.77   0.33
  GO:0016817           hydrolase activity, acting on acid anhydrides                                        7,223%     --22.918    0.80   0.37

Crosstalk Between SmJNK and Smp38 MAPK Pathways {#s3_6}
-----------------------------------------------

Since the JNK and p38 MAPK signaling pathways are triggered by multiple stimuli that simultaneously activate both pathways and consequently share several upstream regulators ([@B59]), we compared the DEGs found here with those found for Smp38 knocked-down schistosomula ([@B4]). The SmJNK and Smp38 MAPK pathways in *S. mansoni* presented an intersection of 311 and 89 genes with decreased and increased expression, respectively ([**Figure 6**](#f6){ref-type="fig"}).

![Overlap of DEGs in schistosomula knocked-down for SmJNK and Smp38 MAPKs. Venn diagram representing the number of genes with a decrease **(A)** or increase (B) in gene expression after exposure to SmJNK or Smp38 dsRNAs. In red are represented DEGs regulated by Smp38, in blue SmJNK, and in pink are the overlapping DEGs in both datasets.](fgene-10-01036-g006){#f6}

Of the 311 down-regulated genes identified in common for SmJNK and Smp38 knockdown schistosomula, we found orthologs for 221 of them, which correspond to 291 different genes in *C. elegans*, since some of the genes present more than one ortholog. The *C. elegans* orthologs are enriched in genes related to the RNAi phenotypes as described: sterile, embryonic lethal, maternal sterile, larval arrest, transgene subcellular localization variant, slow growth, among others ([**Figure 7**](#f7){ref-type="fig"} and [**Supplementary Table S4**](#SM2){ref-type="supplementary-material"}).

![C*. elegans* RNAi phenotypes enriched in orthologues from down-regulated genes in SmJNK and Smp38 knockdown schistosomula. Worm Enrichr analysis was performed to identify the most significantly enriched RNAi phenotypes listed based on the P-value. The length of the bar represents the significance of that specific term. In addition, the brighter the color, the more significant that term is.](fgene-10-01036-g007){#f7}

Discussion {#s4}
==========

We advanced the understanding of SmJNK gene function by demonstrating that SmJNK is involved in parasite reproduction *in vitro*. We observed a significantly lower number of eggs recovered from SmJNK knocked-down adult worms compared to the control group. It was previously shown that SmJNK knockdown decreased parasite survival and maturation within the definitive host, and that female worms treated with SmJNK dsRNA showed undifferentiated oocytes ([@B1]). SmJNK is highly expressed in the ovary of paired females ([@B36]; [@B37]), evidencing its role in female reproduction. Therefore, in *in vitro* adult females, SmJNK knockdown may influence oocyte maturation, since the ovary is already fully formed prior to the SmJNK knockdown. This is particularly promising as the eggs are fundamentally related to the disease pathology. Granulomas are the result of host immune response to schistosome eggs. Its formation is triggered by immune cells migration to encapsulate the eggs, resulting in damage of liver tissue (fibrosis and, ultimately, cirrhosis) ([@B15]; [@B30]; [@B10]). Additionally, in *in vitro* cultured adult worms, SmJNK does not seem to have a role in parasite movement or viability.

Protein kinases domains are highly conserved between organisms ([@B39]). Therefore, any drug development effort needs to consider cross-binding of a small molecules that could result in undesired potential side effects. Inhibitors need to be specific and to target essential proteins. The elucidation of gene targets regulated by SmJNK, in addition to contributing to a better understanding of the JNK signaling pathway in *S. mansoni* parasite, also aims at searching for parasite-specific targets. Among the identified DEGs are some proteins with unknown function, these genes could be schistosome-specific. Such proteins may be related to the previously observed phenotypes of parasite development and oviposition impairment.

We observed the down-regulation of genes related to the structural composition of ribosomes in SmJNK knockdown parasites. Ribosomal proteins are major components of ribosomes and play critical roles in protein biosynthesis. Variations observed in the expression of ribosomal proteins in different human tissues are probably related to extraribosomal functions ([@B9]), since ribosomal proteins and RNAs are typically synthesized in stoichiometric amounts ([@B38]). Also, the differential expression of ribosomal proteins has been reported in several pathological ([@B7]) and stress conditions ([@B60]).

Genes related to the cytoskeleton showed decreased expression when SmJNK was knocked-down. Integrin-linked kinase (ILK) an activator of the SmJNK, extracellular signal-regulated kinase (SmERK), and Akt pathways, is involved in cytoskeletal reorganization and cell survival. The dysregulation of SmILK may contribute to errors in cell division and genomic instability ([@B17]). The SmILK signaling pathway has an influence on egg production, ovarian structure, and oocyte integrity in female schistosomes ([@B19]), with similar phenotypes to those observed for SmJNK knockdown ([@B1]).

Among genes with decreased expression after SmJNK knockdown, we observed genes related to protein folding, such as chaperonins and heat shock proteins (HSPs). Cellular chaperones such as HSPs confer resistance to stress, promoting cell survival. Prolonged oxidative stress causes an increase in misfolded proteins that aggregate in the endoplasmic reticulum. The objective of the endoplasmic reticulum stress response is to inhibit or retard protein synthesis. This is achieved by the phosphorylation of eukaryotic translation initiation factor 2 (eIF2a) by protein kinase R--like endoplasmic reticulum kinase or by JNK ([@B46]). SmJNK knockdown may have inhibited this stress response, resulting in the observed down-regulation of chaperone and HSPs gene expression.

In rat fibroblasts, positive regulation of the p38 and JNK signaling pathways promotes increased expression of the plasminogen activator inhibitor 1 (PAI-1) ([@B48]). JNK modulates positively the PAI-1 expression in the neurodegenerative amyloid pathology observed in Alzheimer's disease ([@B20]), whereas JNK inhibition significantly attenuates the induction of PAI-1 ([@B16]). PAI-1 was not detected among DEGs in SmJNK and Smp38 knockdown schistosomula. However, the expression of plasminogen activator inhibitor 1 RNA-binding protein (SERBP1, Smp_009310), which plays a role in regulating the PAI-1 mRNA stability, was down-regulated ([**Figure 4B**](#f4){ref-type="fig"}). *Schistosoma* inhibits host coagulation during infection through stimulation of fibrinolytic pathways ([@B42]). The interaction between parasites and the hosts' fibrinolytic system results in the regulation of several functions related to parasite survival mechanisms. For example, the degradation of immunoglobulins and complement components, the activation of matrix metalloproteinases, the stimulation of adhesion, and the degradation of proteins for nutrition ([@B22]). The detected reduction in the SERBP1 transcript levels, could influence PAI-1 stability, therefore, may interfere in parasite feeding and/or reduce mobility in the host, thus, be related to the parasite survival impairment ([@B1]).

SmJNK knockdown also down-regulated genes involved in RNA splicing. Alternative splicing events alter the protein repertoire of the cells being regulated by the expression patterns of the splicing factors ([@B24]). The splicing control is as complex and relevant as the transcriptional control ([@B31]). It has already been shown that JNK signaling pathway controls splicing events in human T cells ([@B41]). This pathway also seems to act in the regulation of alternative splicing in response to extracellular stimuli, promoting changes in splicing patterns ([@B49]). Moreover, *Schistosoma* presents trans-splicing, which is a peculiar mechanism that shares the proteins from the spliceosome, could affect up to 58% of transcripts in the cercarial stage ([@B8]). It has been suggested as a target for parasite impairment and would be affected by the alterations detected in categories related to RNA splicing ([@B44]).

The ability to deal with adverse environmental conditions is a fundamental need for all organisms, especially parasites. It is, therefore, not surprising that stress-activated protein kinase pathways are among the oldest and most conserved metazoan signaling modules ([@B58]). The JNK and p38 MAPK pathways share several upstream regulators and, consequently, multiple stimuli simultaneously activate both pathways ([@B59]). Several studies demonstrate that the extracellular signal-regulated kinase (ERK), JNK, and p38 MAPK signaling pathways act cooperatively, amplifying and integrating signals from various stimuli; promoting appropriate physiological responses including cell proliferation, differentiation, development, inflammatory responses, and apoptosis in mammalian cells ([@B62]).

Orthologs of SmJNK and Smp38 in *C. elegans* regulate phenotypes that result in sterile nematodes. Hence, oocyte morphology alterations, decreased number or lack of this structure, and gonad alterations are redundant terms among the enriched RNAi phenotypes in the orthologs. The JNK (named kgb-1) deletion in *C. elegans* has a sterile phenotype, characterized by the massive presence of immature oocytes ([@B54]). The *C. elegans* kgb-1 deleted mutant presents low reproduction rate and shortened lifespan, concomitantly with reduced expression of genes for protein biosynthesis, chaperones, and enzymes involved in ubiquitination/proteasomal degradation ([@B21]). All those findings corroborate the phenotypes and transcription profile associated with SmJNK and Smp38 knockdown.

Here we have shown that SmJNK activity is related to the reduction of egg production *in vitro*. This is in accordance with previously observed phenotype alterations *in vivo*, that demonstrated that SmJNK and Smp38 inhibitors could lead to sterile females, thereby reducing schistosomiasis pathology in the host. Our results point to other key regulatory proteins that are not well conserved between host and parasite, encouraging the development of small-molecule inhibitors.
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